Centro de Imagem Diagnósticos S.A. (“Alliar”)
Category B projects have potential environmental and/or social impacts and risks that are less adverse than those of a Category A and which are generally limited to the project site, largely reversible and can be mitigated via measures that are readily available and feasible to implement in the context of the operation.
Projected date at which a project will be put forward for the Board of Executive Directors’ approval.
Projected board date
Matas Trillo, Rafael
USD $ 43,152,600
Project scope and objective
The Project consists on the re-financing of Alliar’s short-term debt and the financing of its medium-term capex expansion (the “Project”). The proceeds of the loan will go to the re-financing of the Company’s short-term debt for up to R$107 million, and the financing of the Company’s medium-term CAPEX investments for up to R$103 million with a tenor of eight years door-to-door. As a result, IDB Invest will help Alliar to implement a financial strategy that will allow them in the long term to leverage and secure their growth initiatives within the Brazilian medical diagnostics market. The most significant development effects that will derive from the Project are as follows: (i) expanded provision of health care services; (ii) improved quality of health care services; (iii) enhanced health care services through technological and digital innovation; (iv) increase productivity and operational efficiencies.
For inquiries, comments and information requests about the projectRequest information
Alternatively, you may also use the following contact information:
+55 11 94854-0458
IDB Invest Contact
1350 New York Ave NW, Washington, DC 20005